NEW YORK (GenomeWeb News) – BioTrove said this week that it has installed its RapidFire High-Throughput Mass Spectrometry screening platform with its first European customer. The firm said that Boehringer Ingelheim is using the system for expanded in vitro ADME applications. It also noted that BI had installed a Rapid Fire system at its Laval, Canada, site.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.